Insulin-leptin-visceral fat relation during weight loss
1Center for Human Nutrition, School of Medicine, University of California at Los Angeles, 90095-1742, USA. iyip@mednet.ucla.edu
Pancreas
|August 4, 2001
Summary
This study shows that insulin and leptin levels are closely related during weight loss, with insulin potentially regulating leptin secretion. The findings highlight the effectiveness of a calorie-deficient diet and sibutramine in reducing body weight and visceral fat.
Area of Science:
- Endocrinology
- Metabolism
- Obesity Research
Background:
- The relationship between the insulin-leptin-visceral fat axis during weight loss remains understudied.
- Upper body obesity is a significant health concern linked to metabolic dysfunction.
Purpose of the Study:
- To investigate the interplay between insulin, leptin, and abdominal adiposity during a weight loss intervention.
- To evaluate the impact of a calorie-deficient diet combined with sibutramine on these metabolic markers.
Main Methods:
- A 6-month clinical study involving 20 volunteers with upper body obesity.
- Participants received a calorie-deficient diet and escalating doses of sibutramine.
- Serial measurements included body weight, insulin, leptin, glucose, lipids, and abdominal fat via CT scans.
Main Results:
- Significant reductions in body weight (16.0%), total body fat (22.5%), and abdominal fat depots (visceral: 31.0%, subcutaneous: 26.0%) were observed.
- Leptin and insulin levels decreased significantly by week 4 (32.0% and 37.9%, respectively), with insulin potentially regulating leptin secretion.
- A strong correlation was found between insulin and leptin concentrations, and between leptin and visceral/subcutaneous abdominal fat.
Conclusions:
- Insulin and leptin are significantly related during weight loss, suggesting insulin's role in regulating leptin secretion.
- The combination of a hypocaloric diet and sibutramine effectively reduces body weight and abdominal fat.
- Further research is needed to determine if sibutramine selectively reduces visceral abdominal fat.
More Related Videos
06:08Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
10:40Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro
Published on: December 5, 2025
Related Concept Videos
01:02Hypodermis
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:24Metabolic States of the Body: Fasting and Starvation
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...